important annc, page-10

That is great news . The patients who are recruited for these type of trials have refractory cancers(resistant to all available cancer treatments) They are out of options , and the future is bleak . If some can be helped it has been worthwhile . As dosage is increased , even better results should be seen before the end of this Phase1 trial I hope .